ライフサイエンスコーパス: aphakic

1 congenital cataracts and was presumed to be aphakic.

2 went primary IOL implantation and those left aphakic.

3 nterior chamber intraocular lens or who were aphakic.

4 mplicated intraocular lens placement or were aphakic.

5 d a sulcus intraocular lens, and 2 eyes were aphakic.

6 or/posterior segment anomalies who were left aphakic.

7 Ten patients (91%) were initially left aphakic.

8 ve lens material centrally but was not truly aphakic.

9 traocular lens (IOL) placement; 15 were left aphakic.

10 rior chamber occurred in 6 patients who were aphakic, 4 patients with an anterior chamber intraocular

11 n was more common in pseudophakic (32%) than aphakic (8%) eyes (P = 0.009).

12 cular lens (IOL) implantation than eyes left aphakic achieved >/=20/40 postoperatively (71% vs 52%).

13 male; mean [SD] age, 0.89 [1.97] years) were aphakic after lensectomy, and 606 eyes of 489 children (

14 s, 5 (29%) had Marfan syndrome, 2 (12%) were aphakic after pars plana vitrectomy and 4 (24%) were aph

15 after pars plana vitrectomy and 4 (24%) were aphakic after surgical intervention for trauma.

16 teral cataract, we recommend leaving the eye aphakic and focusing the eye with a contact lens.

17 ent, 20/45; range, 0.00-1.18 logMAR) in both aphakic and pseudophakic children.

18 Aphakic and pseudophakic eyes and eyes with best correct

19 sed to adjust the optical correction of both aphakic and pseudophakic eyes to a near point (3-5 D).

20 erence between the mean axial lengths of the aphakic and pseudophakic eyes was not significant (P > 0

21 Aphakic and pseudophakic eyes were excluded as well as e

22 At 5 weeks of age, aphakic and pseudophakic eyes were significantly shorter

23 , to the eyes of 19 monkeys made monocularly aphakic as neonates, and to the eyes of 39 normal monkey

24 h America), pseudophakic bullous keratopathy/aphakic bullous keratopathy (North America), and keratit

25 mmon indication for DMEK was pseudophakic or aphakic bullous keratopathy (PBK), followed by graft fai

26 elated QOL was associated with OAG, PSC, and aphakic cataract surgery, as assessed by the NEI-VFQ-25

27 Patients that appear to be aphakic centrally may still present with angle closure s

28 visual acuity improved from 1.08 +/- 0.65 in aphakic children to 0.55 +/- 0.51 logarithm of the minim

29 Extended-wear aphakic CLs may cause corneal polymegathism with increas

30 s-claw intraocular lens (RPICIOL) in several aphakic conditions without capsular support.

31 nd populations in whom accessing or managing aphakic contact lenses is challenging.

32 l dystrophy (94% of eyes) or pseudophakic or aphakic corneal edema (6% of eyes).

33 rophy (1255 eyes [94.4%]) or pseudophakic or aphakic corneal edema (75 eyes [5.6%]).

34 incipally Fuchs dystrophy or pseudophakic or aphakic corneal edema (PACE).

35 ncipally Fuchs' dystrophy or pseudophakic or aphakic corneal edema, were enrolled by 105 surgeons fro

36 traocular lenses, and 40.3% of them required aphakic correction.

37 er surgery, visual acuity was 20/125 OS with aphakic correction.

38 ent prophylactic lensectomy and was 20/30 in aphakic correction.

39 eudophakic eyes (21%; 95% CI, 10%-38%) and 1 aphakic eye (13%; 95% CI, 2%-47%).

40 ge, 20/40 to 20/100) in 182 of 316 bilateral aphakic eyes (58%), 20/32 (range, 20/25 to 20/50) in 209

41 e, 20/50 to 20/618) in 124 of 202 unilateral aphakic eyes (61%), and 20/65 (range, 20/32 to 20/230) i

42 pseudophakic eyes (95% CI, 1%-16%) and 9% in aphakic eyes (95% CI, 0%-24%).

43 eudophakic eyes (95% CI, 31%-60%) and 13% in aphakic eyes (95% CI, 0%-28%).

44 44 (43% [95% CI 32%-54%]) unilateral non-PFV aphakic eyes (age-adjusted odds ratio = 1.90 [95% CI 0.8

45 2 [3.0] years) and 20/258 (20/56-<20/800) in aphakic eyes (n = 8; mean [SD] age at surgery, 5.5 [4.3]

46 nt neovascular complications were greater in aphakic eyes after diabetic vitrectomy, and subsequently

47 es with pseudophakia; 7% (95% CI, 5%-10%) of aphakic eyes and 3% (95% CI, 2%-5%) of pseudophakic eyes

48 ts aged from 41 to 50, high-risk recipients, aphakic eyes and eyes with anterior chamber intraocular

49 Mean EC densities were higher in aphakic eyes compared with fellow eyes (3921 vs. 3495 ce

50 al cells was lower (72% vs. 76%, P=0.002) in aphakic eyes compared with fellow eyes.

51 ctive observational study in 59 aniridic and aphakic eyes for ArtificialIris (AI) and IOL reconstruct

52 Aphakic eyes showed worse visual acuity (VA) than phakic

53 uity was significantly poorer than normal in aphakic eyes treated only with EWCLs.

54 Mean CCT of aphakic eyes was higher than in controls (637 vs. 563 mu

55 e mean axial lengths of the pseudophakic and aphakic eyes were 2.0 +/- 0.2 mm and 2.3 +/- 0.2 mm, res

56 Aphakic eyes were excluded from analysis.

57 IQR, -11.38 D to -2.75 D) among 89 bilateral aphakic eyes, -1.63 D (IQR, -3.13 D to -0.25 D) among 13

58 Among aphakic eyes, a higher risk for glaucoma-related adverse

59 QR, -20.50 D to -4.50 D) among 43 unilateral aphakic eyes, and -1.94 D (IQR, -3.25 D to -0.69 D) amon

60 ive BCVA at 6 months or more in pseudophakic/aphakic eyes.

61 ases, with minor modifications in phakic and aphakic eyes.

62 etween the PPV and SB groups in pseudophakic/aphakic eyes.

63 amblyopic deficits in both pseudophakic and aphakic eyes.

64 had significantly better gating acuity than aphakic eyes.

65 with elevated risk of the adverse events in aphakic eyes.

66 ior chamber intraocular lens [IOL], 2.83 for aphakic eyes; P < 0.001), and IOL exchange or removal du

67 receipt of an intraocular lens vs being left aphakic for the first 5 years of life.

68 ight conditions, including enlarged eyes, an aphakic gap, a tapetum lucidum, and a pure rod retina wi

69 ary open angle glaucoma (POAG) and infantile aphakic glaucoma (IAG) are significant contributors of v

70 tal glaucoma was present in 39 eyes (88.6%), aphakic glaucoma in 4 eyes (9.1%), and Peters anomaly-as

71 gnoses, such as primary congenital glaucoma, aphakic glaucoma, and glaucomas associated with other oc

72 slocation with sutured IOLs and the risks of aphakic glaucoma.

73 In the pseudophakic/aphakic group, there were no significant differences in

74 sts accounted for 15% ($1600/patient) in the aphakic group, whereas glasses costs represented only 4%

75 ne half of the patients in the contact lens (aphakic) group eventually undergo secondary IOL implanta

76 Combining phakic, pseudophakic, and aphakic groups, those treated with scleral buckle alone

77 More poor vision eyes were aphakic, had higher medication burden, and had ocular co

78 onths of age militates toward leaving babies aphakic if it is considered likely that the family will

79 The eyes were left aphakic in the remaining 9 animals.

80 After excluding pseudophakic and aphakic individuals, the study included 5,451 (92.4%) pa

81 ophakic (r(Spearman) = -0.41, p < 0.01) than aphakic infants (r(Spearman) = -0.10, p = 0.49).

82 ular support had posterior chamber iris-claw aphakic IOL implantation between 2007 and 2012.

83 e and a traumatic dislocation of a posterior aphakic iris-claw IOL in 1 eye.

84 The posterior implantation technique of aphakic iris-claw IOL provided good visual outcomes with

85 Infants were either left aphakic (n = 53) or had an intraocular lens implanted (n

86 verse events between PFV and non-PFV eyes in aphakic participants <=1 year of age at lensectomy (age-

87 One aphakic patient required topical therapy for glaucoma.

88 stimated for both phakic and pseudophakic or aphakic patients and then were compared.

89 Six out of 10 (60%) aphakic patients developed visual axis opacification.

90 However, in pseudophakic and aphakic patients, PPV seems to be less expensive than SB

91 ve than SB for RRD repair in pseudophakic or aphakic patients.

92 sis was divided into phakic and pseudophakic/aphakic patients.

93 eved in 17 (59% [95% CI 39%-76%]) unilateral aphakic PFV eyes and 44 (43% [95% CI 32%-54%]) unilatera

94 The most common complication in aphakic PFV eyes was glaucoma-related adverse events (cu

95 Forty-eight of 64 eyes were aphakic postoperatively (median age at surgery 2 months

96 ntraoperative aberrometry (ORA) was used for aphakic refraction and IOL power calculation during surg

97 so Viejo, CA) wavefront aberrometer measured aphakic refractive measurements intraoperatively and cal

98 tem wavefront aberrometer was used to obtain aphakic refractive measurements intraoperatively and the

99 48 eyes in 46 patients with implantation of aphakic, snap-on type 1 Boston KPros performed at a tert

100 postoperative complications in patients with aphakic, snap-on type I Boston keratoprostheses (KPros).

101 underwent total PPVs during implantation of aphakic, snap-on, type I Boston KPros had less postopera

102 sular bag has become the standard of care in aphakic state.

103 vitrectomy to later than 2 weeks, and final aphakic status were independently predictive of 20/200 o